Control Bionics (ASX:CBL) Receivables Turnover : 1.71 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Control Bionics's Revenue for the six months ended in Dec. 2024 was A$2.78 Mil. Control Bionics's average Accounts Receivable for the six months ended in Dec. 2024 was A$1.62 Mil. Hence, Control Bionics's Receivables Turnover for the six months ended in Dec. 2024 was 1.71.

Control Bionics Receivables Turnover Historical Data

The historical data trend for Control Bionics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Receivables Turnover Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Receivables Turnover

5.86

4.54

3.77

3.25

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Receivables Turnover	Get a 7-Day Free Trial				2.00	1.72	1.61	1.33	1.71

Competitive Comparison of Control Bionics's Receivables Turnover

For the Medical Devices subindustry, Control Bionics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics's Receivables Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Control Bionics's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Control Bionics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Control Bionics's Receivables Turnover for the fiscal year that ended in Jun. 2024 is calculated as

	Receivables Turnover (A: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jun. 2024 )	/ (	(Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )
=	5.127	/ (	(1.622	+	1.534)	/	2 )
=	5.127	/	1.578
=	3.25

Control Bionics's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	2.778	/ (	(1.534	+	1.709)	/	2 )
=	2.778	/	1.6215
=	1.71

Control Bionics (ASX:CBL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Control Bionics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Control Bionics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.